These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 3095098

  • 21. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV, Shyr SW, Grosvenor CE, Crowley WR.
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [Abstract] [Full Text] [Related]

  • 22. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
    Pilotte NS, Burt DR, Barraclough CA.
    Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen.
    Gabriel SM, Simpkins JW, Kalra SP.
    Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330
    [Abstract] [Full Text] [Related]

  • 25. The influence of oestrogen administration in vivo on in vitro prolactin release. Interaction between dopamine and thyrotrophin releasing hormone.
    Jaques S, Gala RR.
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):437-47. PubMed ID: 117662
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.
    Bression D, Brandi AM, Pagesy P, Le Dafniet M, Martinet M, Brailly S, Michard M, Peillon F.
    Endocrinology; 1985 May; 116(5):1905-11. PubMed ID: 3987624
    [Abstract] [Full Text] [Related]

  • 29. [Validity of radioimmunoassay for blood and pituitary prolactin in the male rat. Effect of bromocriptine and thyrotropin-releasing hormone].
    André M, Grizard G, Boucher D.
    C R Seances Soc Biol Fil; 1981 May; 175(6):792-800. PubMed ID: 6459824
    [Abstract] [Full Text] [Related]

  • 30. Regulation of pituitary gonadotropin-releasing hormone (GnRH) receptors by pulsatile GnRH in female rats: effects of estradiol and prolactin.
    Duncan JA, Barkan A, Herbon L, Marshall JC.
    Endocrinology; 1986 Jan; 118(1):320-7. PubMed ID: 3000743
    [Abstract] [Full Text] [Related]

  • 31. Interaction between triiodothyronine and ovarian steroid hormones on the regulation of the release of thyrotropin and thyrotropin-releasing hormone in vitro.
    Liu SR, Tsai SC, Lu CC, Lee KY, Liu TC, Pu HF, Wang PS.
    Chin J Physiol; 1997 Dec 31; 40(4):221-6. PubMed ID: 9551251
    [Abstract] [Full Text] [Related]

  • 32. Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries.
    Aguilar R, Bellido C, Garrido-Gracia JC, Alonso R, Sánchez-Criado JE.
    Reproduction; 2006 Apr 31; 131(4):763-9. PubMed ID: 16595727
    [Abstract] [Full Text] [Related]

  • 33. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges.
    Bauer-Dantoin AC, McDonald JK, Levine JE.
    Endocrinology; 1992 Dec 31; 131(6):2946-52. PubMed ID: 1446632
    [Abstract] [Full Text] [Related]

  • 34. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
    Murai I, Garris PA, Ben-Jonathan N.
    Endocrinology; 1989 May 31; 124(5):2343-9. PubMed ID: 2495929
    [Abstract] [Full Text] [Related]

  • 35. Involvement of postnatal gonads in the maturation of dopaminergic regulation of prolactin secretion in female rats.
    Watanobe H, Takebe K.
    Endocrinology; 1987 Jun 31; 120(6):2212-9. PubMed ID: 3569131
    [Abstract] [Full Text] [Related]

  • 36. Quantification of vasoactive intestinal peptide immunoreactivity in the anterior pituitary glands of intact male and female, ovariectomized, and estradiol benzoate-treated rats.
    Carrillo AJ, Phelps CJ.
    Endocrinology; 1992 Aug 31; 131(2):964-9. PubMed ID: 1639033
    [Abstract] [Full Text] [Related]

  • 37. [The control of prolactin surge by ovarian steroids in the early phase of pseudopregnancy in rats (author's transl)].
    Kishi K, Kobayashi F.
    Nihon Naibunpi Gakkai Zasshi; 1981 May 20; 57(5):762-71. PubMed ID: 7197236
    [Abstract] [Full Text] [Related]

  • 38. Effects of ovarian hormone treatment on the gene expression of muscarinic acetylcholine receptors in the ovariectomized rat myometrium.
    Yasuda K, Sumi G, Kanamori C, Nakajima T, Tsuzuki T, Cho H, Nishigaki A, Okada H, Kanzaki H.
    J Steroid Biochem Mol Biol; 2014 Sep 20; 143():81-9. PubMed ID: 24583025
    [Abstract] [Full Text] [Related]

  • 39. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
    Pohl CR, Weiner RI, Smith MS.
    Endocrinology; 1988 Sep 20; 123(3):1591-7. PubMed ID: 3402398
    [Abstract] [Full Text] [Related]

  • 40. Estrogen-induced calbindin-D 9k gene expression in the rat uterus during the estrous cycle: late antagonistic effect of progesterone.
    L'Horset F, Blin C, Brehier A, Thomasset M, Perret C.
    Endocrinology; 1993 Feb 20; 132(2):489-95. PubMed ID: 8425470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.